MAP2K7 and melanoma: Recently, Liu et al. reported the activation of nuclear beta-catenin signaling in melanoma CAFs during the development of resistance to BRAF inhibitor or MEK inhibitors, underscoring the role of BRAF-inhibitor-induced CAF reprogramming in matrix remodeling and the therapeutic escape of melanoma cells [80].